Brief: Sirnaomics Receives Regulatory Clearance On IND Application From U.S. FDA
27/04/2023 14:57
April 27 (Reuters) - Sirnaomics Ltd 2257.HK :
* RECEIVED REGULATORY CLEARANCE ON IND APPLICATION FROM US
FOOD
AND DRUG ADMINISTRATION COMMENCE A PHASE I CLINICAL TRIAL FOR
RV-1730
* RNAIMMUNE RECEIVES IND CLEARANCE FROM FDA FOR PHASE I
CLINICAL
STUDY OF RV-1730 COVID-19 BOOSTER VACCINE
Source text for Eikon: ID: company coverage: 2257.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sirnaomics
See all newsBrief: Sirnaomics Announces RMB30 Million Capital Injection For Deemed Disposal
Brief: Sirnaomics And Unit Files Writ Of Summons Against Former Management
Brief: Sirnaomics To Issue 2.4 Million New Shares At Hk$4.69 Each Under General Mandate
Brief: Sirnaomics Says Chairman Purchases 38,000 Shares At Average Price Hk$5.93 Per Share
Brief: Sirnaomics Ltd To Issue 17.4 Million Subscription Shares